Epstein Secrets

tin, should we try to touch base on Monday? The rest of the week is pretty much shot for me with visitors. Best, Don > On Dec 2, 2016, at 9:32 AM, Nowak, Martin A. < > Don , Jeffrey > wrote: EFTA00636423 > I would like to put you in direct email contact. > also cc Lesley. >m please note The i

er — under Bush II — was a partial PhD student of mine when he was getting his MD at Harvard and his PhD in Econ at MIT, and remains a good friend: Mark McClellen, who is interested in this stuff and remains quite influential in DC, I think). But the reason for rambling about the FDA and placebo effects is th

tin, should we try to touch base on Monday? The rest of =he week is pretty much shot for me with visitors. Best, Don > On Dec 2, 2016, at 9:32 AM, Nowak, Martin A. <[email protected]> wrote: > Don , Jeffrey > I would like to put you in direct email contact. > also cc Lesley. >m please note

er — under Bush II — was a partial PhD student =f mine when he was getting his MD at Harvard and his PhD in Econ at =IT, and remains a good friend: Mark McClellen, who is interested in =his stuff and remains quite influential in DC, I think). =nbsp; But the =eason for rambling about the FDA and placebo effects

nday?1> The rest of the week is pretty much shot for me with visitors. Best, Don 3 EFTA_R1_01918722 EFTA02667103 > On D=c 2, 2016, at 9:32 AM, Nowak, Martin A. <mailto: wrote: > Don , Jeffrey > I would like to put you in direct email contact. <=r>> > also cc Lesley. &g=; =br class="m_-4784

ner — under Bush II — was a pa=tial PhD student of mine when he was getting his MD at Harvard and his PhD=in Econ at MIT, and remains a good friend: Mark McClellen, who is interest=d in this stuff and remains quite influential in DC, I think). But the reason for ra=bling about the FDA and placebo effects is th

8783 EFTA02667150 > On Dec 2, =016, at 9:32 AM Nowak Martin A <mai > wrote:=br class="m 119680578881

2401, under Bush II — was a partial PhD student of mine when he=was getting his MD at Harvard and his PhD in Econ at MIT, and remains a go=d friend: Mark McClellen, who is interested in this stuff and remains quit= influential in DC, I think). But the reason for rambling about the FDA and placebo eff=cts is th

? =he rest of the week is pretty much shot for me with visitors. 2 EFTA_R1_01919123 EFTA02667399 Best, Don =br> > On Dec 2, 2016, at 9:32 AM, Nowak, Martin A. «= href="mailto class="m_-1196805788815373682g=ail_msg" target="_blank" wrote: > Don , Jeffrey > I w=uld like to put you in direct ema

Q=80Q under Bush II — was a partial PhD student of mine when he wa= getting his MD at Harvard and his PhD in Econ at MIT, and remains a good =riend: Mark McClellen, who is interested in this stuff and remains quite i=fluential in DC, I think). EFTA_R1_01919122 EFTA02667398 But the reason for rambling about

tin, should we try to touch base on Monday? The rest of the =eek is pretty much shot for me with visitors. Best, Don > On Dec 2,=2016, at 9:32 AM, Nowak, Martin A wrote: > Don=, Jeffrey > I would like to put you in direct email contact. 3 EFTA_R1_01919685 EFTA02667792 ><=r class="m_-6698346136

ner — under Bush II — was a pa=tial PhD student of mine when he was getting his MD at Harvard and his PhD=in Econ at MIT, and remains a good friend: Mark McClellen, who is interest=d in this stuff and remains quite influential in DC, I think). But the reas=n for rambling about the FDA and placebo effects is th